Polymorphism of CCR5 affecting HIV disease progression in the japanese population

AIDS Research and Human Retroviruses

Volumn 17, Issue 11, 2001, Pages 991-995

  Kageyama, Seiji ^a   Mimaya, Jun Ichi ^b   Yamada, Kaneo ^c   Kurimura, Takashi ^d   Shiraki, Kimiyasu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b SHIZUOKA CHILDREN'S HOSPITAL   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HAPLOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JAPAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN DOMAIN; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; DISEASE PROGRESSION; HAPLOTYPES; HEMOPHILIA A; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; JAPAN; LINKAGE (GENETICS); POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CCR5; REGULATORY SEQUENCES, NUCLEIC ACID;

EID: 0034827756     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922201300343663     Document Type: Article

References (45)

1. Host factors and the pathogenesis of HIV-induced disease
2. Long-term nonprogression in HIV infection: Methodological issues and scientific priorities
3. Brief report absence of intactnef sequences in a long-term survivor with nonprogressive HIV-1 infection
4. High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection
5. Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus
6. Grossly defectivenef gene sequences in a human immunodeficiency virus type 1-seropositive long-term nonprogressor
7. Biological characterization ofnef in long-term survivors of human immunodeficiency virus type 1 infection
8. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
9. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
10. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
11. Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient
12. HIV-1 infection in an individual homozygous for the CCR5 deletion allele
13. HIV-1 infection in a man homozygous for CCR5 delta 32
14. HIV-1 infection in an individual homozygous for CCR5 delta 32. Seroco Study Group
15. Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals
16. HIV-infected individuals with the CCR delta32/CCR5 genotype have lower HIV RNA levels and higher CD4 cell counts in the early years of the infection than do patients with the wild type. Copenhagen AIDS Cohort Study Group
17. Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression Relationship with viral load. The SEROCO Study Group
18. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression
19. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
20. Genetic polymorphism of CCR5 gene and HIV disease: The heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression
21. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression
22. Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: Association with low expression of CCR5 and high production of beta-chemokines
23. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro
24. Chemokine-receptor polymorphisms: Clarity or confusion for HIV-1 prognosis?
25. Coreceptors: Implications for HIV pathogenesis and therapy
26. A new classification for HIV-1
27. The human CC chemokine receptor 5 (CCR5) gene. Multiple transcripts with 59-end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons
28. Cloning, in vitro expression and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2B
29. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3
30. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation
31. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression
32. Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus
33. CCR2 polymorphism HIV disease
34. The role of the C-C chemokine receptor 2 gene polymorphism V64I (CCR2-64I) in sarcoidosis in a Japanese population
35. Influence of CCR5 promoter haplotypes on AIDS progression in African-Americans
36. Genetic acceleration of AIDS progression by a promoter variant of CCR5
37. Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes
38. Genetics of HIV-1 infection: Chemokine receptor CCR5 polymorphism and its consequences
39. Global distribution of the CCR2-64I/CCR5-59653T HIV-1 disease-protective haplotype
40. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression
41. Seronegative HIV-2 carriers in India
42. Chemokines and chemokine receptors: Role in HIV infection
43. Long-term non-progression in HIV infection: Clinicopathological issues
44. Long-term non-progression in HIV infection: Definitions and epidemiological issues
45. Influence of host genes on HIV-1 disease progression